The Audit File Is the Real Test: Heavy-Metal Screening Beyond the Slogan
Heavy-metal screening is easy to turn into a slogan. A supplier can place the words on a product page, add a tick-box graphic, and leave the researcher with little more than a marketing impression. For materials managers and laboratory researchers, that is not enough. In research-use-only supply, heavy-metal screening should function as a documentation check within a documented materials audit: a traceable line of evidence that can be linked to a batch, a certificate and a stored vial. The question is not simply whether the phrase appears, but whether the supporting record can be opened, read and reconciled with the material in hand. Research Sciences describes its framework as including heavy metals and endotoxin screening alongside CoA documentation; that description is useful only when the batch document is checked directly. The materials remain for controlled laboratory and analytical research only, not for human or veterinary use.
What Heavy-Metal Screening Should Prove in a Materials Audit
A documented materials audit is not a scrapbook of supplier claims. It is a structured record of what was received, how it was identified, which documents were reviewed, where it was stored and what evidence supported release into an in-vitro workflow. Heavy-metal screening belongs in that record as a batch-linked analytical check. The audit should ask which sample was evaluated, which report relates to it, what method is stated, whether the result is on the batch CoA or an associated report, and whether the report reference matches the label. A generic statement that materials are “heavy-metal screened” does not answer those questions. A batch-specific document has a better chance of doing so.
Research Sciences states that full-spectrum testing covers purity, identity, heavy metals and endotoxin evaluation of submitted samples, with CoAs linked to supported products. The homepage also lists contaminant screening and “CoAs Janoshik Analytical Reports”. These are published descriptions and should be reconfirmed against the live page and, more importantly, against the CoA supplied with the specific batch. When reviewing a UK catalogue such as the one presented through Uk peptides, the catalogue entry should be treated as a starting point for document retrieval, not as a substitute for the batch record. The researcher still needs to open the CoA, check the product code and confirm that the report belongs to the material being audited.
Where a CoA includes heavy-metal screening, read it as an auditor rather than a shopper. Site-published educational guidance discusses heavy-metal testing by ICP-MS, but the presence of a method name should not be over-read. If the CoA states a method, record it. If it states results, record them with the certificate reference. If limits, sample preparation details or traceability are not visible, do not invent them or infer a pass mark from a marketing phrase. The audit should distinguish between what is documented, what is absent and what requires clarification from the supplier. That distinction is the difference between a documented materials audit and a slogan repeated in a spreadsheet. Materials supplied for this purpose are not medicines or supplements and are not for human or veterinary use.
Reading a CoA as an Auditor, Not a Shopper
Trace identity, batch and label reference
The first task is identity matching. Check the product name, catalogue code, batch or internal test reference, and the vial label. Research Sciences describes vial labels as using a reference format that combines SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. Quote that reference when contacting the shop about documentation. A CoA that cannot be matched to the label is not a completed check; it is an open item. The same principle applies across catalogue examples such as BPC-157 10mg, TB-500 5mg, GHK-Cu 50mg, Tesamorelin 5mg or MT-1 10mg: each listing still needs its own batch document review before it enters a recorded in-vitro workflow.
Do not over-read an ITR or packaging
Restocked products may carry the same Internal Test Reference as earlier stock. The shop’s FAQ states that an ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. That is an important audit control. Do not convert an ITR into proof of lot continuity. Likewise, vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. Heavy-metal screening should be documented through the relevant report, not inferred from a coloured cap or a restock notice.
Purity and identity should also be read with care. The homepage publishes a “≥99% Verified Purity” claim and an “Over 99.1% Purity” line; these are current published figures and should be reconfirmed on the live site and on the batch CoA where relevant. The FAQs state that peptides are typically supplied at ≥99% purity by HPLC, with exact purity stated on the CoA. For a materials audit, record the CoA figure rather than a headline figure. If the CoA is missing, hold the item for documentation review and record the missing evidence. Do not release it into a controlled in-vitro study on the strength of a slogan alone. These materials are not for human or veterinary use.
Building the Documented Materials Audit Around Screening
From receipt to recorded release
A practical audit workflow begins at receipt. Verify the label reference, match it to the CoA, record the certificate date in month-and-year form, and note whether heavy-metal screening is reported for that batch or linked through an associated report. Record storage instructions from the product page and CoA, including any lyophilised storage condition such as −20°C protected from moisture and light, and any short-term 2–8°C condition after reconstitution for in-vitro laboratory use. If a vial is reconstituted, record diluent volume and final concentration for the assay only. The shop’s free reconstitution calculator is described for laboratory research use only and must not be used for human or veterinary dosing. These materials are not for human or veterinary use.
Local fulfilment should also be treated as a documentable step rather than a promise. Research Sciences describes tracked domestic fulfilment, temperature-aware storage and next-working-day dispatch, with Royal Mail Tracked 24 usually delivering the following working day as an estimate. The homepage’s “24hr UK Delivery” line is marketing wording; delivery times can vary, so record dispatch and tracking details as received rather than assuming a guarantee. Catalogue items such as Storage Container, 10ml Mixing Water or Bacteriostatic Water 10ml are laboratory accessories and should be logged in the same materials record where they are used in an in-vitro workflow.
The final control is the audit note itself. Record which heavy-metal document was checked, which batch reference it covered, which label reference matched, and what remained unresolved. Where the CoA does not answer a question, record the gap and the supplier query rather than filling it with assumption. That practice keeps heavy-metal screening where it belongs: inside the documented materials audit, supporting the identity, traceability and suitability review of research-use-only materials. The materials are not for human or veterinary use, and the audit should make that limitation explicit at every stage.
